There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Seer (SEER – Research Report) and Biohaven Ltd. (BHVN – Research Report) with bullish sentiments.
Seer (SEER)
TD Cowen analyst Daniel Brennan reiterated a Buy rating on Seer yesterday. The company’s shares closed last Thursday at $1.82, close to its 52-week low of $1.46.
According to TipRanks.com, Brennan is a 4-star analyst with an average return of
Seer has an analyst consensus of Moderate Buy.
See today’s best-performing stocks on TipRanks >>
Biohaven Ltd. (BHVN)
TD Cowen analyst Tyler Van Buren maintained a Buy rating on Biohaven Ltd. yesterday and set a price target of $55.00. The company’s shares closed last Thursday at $48.14, close to its 52-week high of $50.68.
According to TipRanks.com, Buren is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Biohaven Ltd. with a $58.13 average price target, representing a 19.7% upside. In a report issued on February 16, RBC Capital also initiated coverage with a Buy rating on the stock with a $62.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SEER:
- Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
- Seer to Participate in the TD Cowen 44th Annual Health Care Conference
- Seer announces publication of study on Proteograph workflow
- Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
